| Page | ||||
|---|---|---|---|---|
| Report oftheTrustees | 1 | to | 3 | |
| Independent Examiner's |
Report | |||
| Statement ofFinancial Activities | ||||
| Balance Sheet | ||||
| Notes tothe Financial Statements | 7 | to | 10 |
| 2021 | 2020 | |||||
|---|---|---|---|---|---|---|
| Unrestricted | Total | |||||
| fund | funds | |||||
| Notes | f | E | ||||
| INCOME AND ENDOWMENTS | FROM | |||||
| Investment income |
25,165 | 37,636 | ||||
| EXPENDITURE ON | ||||||
| Charitable activities |
||||||
| General donations to other charitable | causes | 38,000 | 34,500 | |||
| Other | 930 | 1 170 | ||||
| Total | 38,930 | 35,670 | ||||
| Net gains/(losses) on |
investments | 215,450 | (201,940) | |||
| NET INCOME/(EXPENDITURE) | 201,685 | (199,974) | ||||
| RECONCILIATION OF |
FUNDS | |||||
| Total funds brought | forward | 808,773 | 1,008,747 | |||
| TOTAL FUNDS CARRIED FORWARD | 1,010,458 | 808,773 |
| 2021 | 2020 | ||
|---|---|---|---|
| Unrestricted | Total | ||
| fund | funds | ||
| Notes | E | E | |
| FIXED ASSETS | |||
| Investments | 1,012,362 | 796,912 | |
| CURRENTASSETS | |||
| Cash at bank | 8,786 | 12,550 | |
| CREDITORS | |||
| Amounts falling due within one year |
(10,690) | (689) | |
| NET CURRENT ASSETS | (1,904) | 11,861 | |
| TOTAL ASSETS LESS CURRENT LIABILITIES | 1,010,458 | 808,773 | |
| NET ASSETS | 1,010 458 7 |
808,773 | |
| FUNDS | |||
| Unrestricted funds |
1,010,458 | 808,773 | |
| TOTALFUNDS | 1010838 | 808 773 |
| 2021 | 2020 | ||||
|---|---|---|---|---|---|
| E | E | ||||
| General donations to other charitable | causes | 38,000 | 34,500 | ||
| The total grants | paid to institutions | during the year was as follows: | |||
| 2021 | 2020 | ||||
| E | E | ||||
| Motor Neurone | 2,000 | 2,000 | |||
| Samaritans | 2,000 | ||||
| EDT Engineering | Trust | 12,500 | |||
| Wye Hops | 10,000 | 10,000 | |||
| Young Classical | Artists Trust | 10,000 | 10,000 | ||
| Read Easy | 12,500 | ||||
| MenCap | 1,500 | ||||
| 38,000 | 34,500 |
| FIXEDASSET INVESTMENTS | |
|---|---|
| Listed | |
| investments | |
| f | |
| MARKET VALUE | |
| At 6 April 2020 | 796,912 |
| Revaluations | 215,450 |
| At 5 April 2021 | 1,012,362 |
| NET BOOK VALUE | |
| At 5 April 2021 | 1,012,362 |
| At 5 April 2020 | 796,912 |
| Market | ||||||
|---|---|---|---|---|---|---|
| Holding | Value | 5.4.21 | 5.4.20 | |||
| E | Df3 | |||||
| Unilever | 345,812 | 34.16N | 43.56ND | |||
| Scottish Mortgage | Investment | Trust | 291,000 | 28.74% | 16.89N | |
| Royal Dutch Shell | 85,172 | 8.41/ | 11.35% | |||
| M&G Equities Investment | Fund | 69,594 | 6.87% | 6.8142I' | ||
| Astrazeneca | 82,478 | 8.1596 | 10.31% | |||
| Prudential | 65,551 | 6.48% | 4.88% |
| 6. | CREDITORS: AMOUNTS | FALLING DUE WITHIN ONE YEAR | ||
|---|---|---|---|---|
| 2021 | 2020 | |||
| E | E | |||
| Trade creditors | 10,000 | |||
| Other creditors | 690 | 689 | ||
| 10,690 | 689 |